Demonstrating the Value of Specialty Medications that Treat Various Cancers

Approximately 40% of Americans will be diagnosed with some type of cancer in their lifetime. Many cancer treatments...

Read More

Demonstrating the Value of Specialty Medications that Treat Multiple Sclerosis

There is no cure for the debilitating disease multiple sclerosis (MS); however, there are treatments that can slow...

Read More

Demonstrating the Value of Specialty Inflammatory Medications

Inflammatory medications are one of the top drivers of specialty drug spend. While these costly drugs can provide...

Read More

Biosimilar Basics: Understanding the Difference Between Generics and Biosimilars

With rising drug costs, we’re all looking for ways to reduce out-of-pocket spend without sacrificing quality. Generic...

Read More

The Journey of Orphan Drugs: History, Development and Costs

Recent attention has been given to rare or orphan diseases—more specifically, to the costs associated with the drugs...

Read More

Embattled Alzheimer's Drug Aduhelm: What You Need to Know

Alzheimer’s is a devastating and deadly disease that affects an estimated 6.5 million Americans age 65 and older, or...

Read More

The Path Back to Normal: Your Questions Answered About COVID-19 Vaccinations

The COVID-19 pandemic has had worldwide impact on our daily lives, creating a new “normal” for most of us. In December...

Read More

Diabetes: A Growing Concern that Needs a Crafted Solution

According to a recent study from the American Heart Association, the prevalence of diabetes has increased by 130% for...

Read More

COVID-19 + Flu Season Equals One More Reason Everyone Should Get a Flu Shot

On average, only about 52% of Americans get vaccinated for the flu every year, according to the Centers for Disease...

Read More